K Health | $50,000,000 | (Jul 2, 2024)
Wify Technologies | $2,993,443 | (Jul 2, 2024)
Pieces for Developers | $13,500,000 | (Jul 2, 2024)
Zetagen Therapeutics
United States
- Syracuse, New York
- 14/08/2023
- Series B
- $9,790,000
Founded in 2015, Zetagen is a private, clinical-stage, biopharmaceutical company dedicated to driving breakthrough innovation in the treatment of metastatic bone cancers and osteologic interventions. Our multi-patented, ZetaMet™ technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. Zetagen exclusively-licensed the platform technology from the State University of New York in 2016.
This novel therapy, a drug-eluting implant technology, has successfully passed its preclinical trials and is being prepared for its first human clinical trial in Q4 2021. In addition to ZetaMet™, the Company’s pipeline includes other oncologic treatments for Skeletal Related Events (SREs), i.e., ZetaMet Flowable™ and ancillary osteologic treatments including, ZetaFuse™, ZetaSet™, ZetaDent™ and ZetaBase™. The Company is supported through Series A funding, private and angel investors, and Phase I and Phase II NIH research grants.
- Industry Pharmaceutical Manufacturing
- Website https://zetagen.com/
- LinkedIn https://www.linkedin.com/company/zetagen-therapeutics/about/
Related People
Joe LoyFounder
United States -
Dallas, Texas
Experienced Executive with a distinguished career in building and leading teams in rapid growth organizations within the Spine & Orthopedic industries. Joe has played key roles in Initial Public Offerings, (IPO), Merger & Acquisitions, (M&A), and National Distribution Agreements with such companies as Stryker/CoAlign, NuVasive, Pfizer/Leibinger, and US Surgical. He also serves as an Advisor & Board of Director for a variety of Spine & Orthopedic implant companies.
N-Power Medicine, Inc. | Undisclosed Amount | (Jul 2, 2024)
Waypoint Bio | $14,500,000 | (Jul 2, 2024)
Feather | $6,429,480 | (Jul 2, 2024)
Comet(INDIA) | $5,000,000 | (Jul 2, 2024)
Innatera | $21,000,000 | (Jul 2, 2024)
Cautio | $778,300 | (Jul 2, 2024)
heymax.ai | Gives You a Free Trip, Every Year. | $2,600,000 | (Jul 2, 2024)
Vytal | The reuse system | $6,644,850 | (Jul 2, 2024)
Smartworks | $12,000,000 | (Jun 28, 2024)